17 February 2021
The UK Government has announced funding to a Phase I clinical trial platform to fast-track research and development of the most innovative Covid-19 treatments. The move will allow the best researchers to study treatments in the UK and will also offer cutting-edge treatments to NHS patients in months rather than years.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Medical research charity LifeArc announced that it will be providing in $6.94m funding to assist the GenOMICC Covid-19 study carried out by the GenOMICC consortium and Genomics England. Launched in May 2020, the study uses genomics to understand why some people are severely affected by Covid-19.
